Fundraising
TANFAC Industries Raises ₹173.5 Crore Through Preferential Issue to Support Growth and Expansion
NSE
not listed
BSE
506854
TANFAC Industries Limited has announced the approval of a preferential issue of equity shares worth approximately ₹173.5 crore, following the successful completion of its Qualified Institutional Placement (QIP) that raised around ₹250 crore. Together, the capital raising initiatives amount to approximately ₹423.5 crore, aimed at funding strategic expansion, including entry into the R-32 refrigerant gas segment and strengthening the company’s financial position.
PRICE-SENSITIVE TRIGGER
Event: Approval of Preferential Equity Issue following completion of Qualified Institutional Placement (QIP).
Type: Fundraising
Impact: Positive
Immediate Effect: The Board approved the issuance of 7,41,082 equity shares on a preferential basis at ₹2,341 per share, aggregating approximately ₹173.5 crore, subject to shareholder and regulatory approvals. Combined with the completed QIP, TANFAC has secured substantial growth capital for future expansion.
Key Metrics:
- Qualified Institutional Placement (Completed): Approximately ₹250 crore
- QIP Shares Allotted: 12,58,918 equity shares
- Date of QIP Allotment: June 25, 2026
- Preferential Issue Size: Approximately ₹173.5 crore
- Preferential Shares: 7,41,082 equity shares
- Issue Price: ₹2,341 per equity share
- Combined Capital Raise: Approximately ₹423.5 crore
- Board-approved Overall Fundraising Limit: Up to ₹500 crore
Highlight:
- The company has secured more than 84% of its approved ₹500 crore fundraising programme through the completed QIP and proposed preferential allotment, providing significant financial resources for its expansion strategy.
What Happened ?
TANFAC Industries announced the successful completion of the first tranche of its approved fundraising programme through a Qualified Institutional Placement, raising approximately ₹250 crore from institutional investors.
Subsequently, the Board approved a preferential issue of equity shares worth around ₹173.5 crore. The proposed allotment includes a significant investment from promoter Anupam Rasayan India Limited, along with participation from institutional investors including Alrox Enterprises Private Limited (part of the Shanghvi Family Office), Vivek Jain (Action Tesa), and Tatvam Trade.
The proceeds will primarily fund the company’s strategic growth initiatives and capacity expansion.
Key Details
Capital Rasie & Expansion Plan:
- Completed QIP raised approximately ₹250 crore.
- Proposed preferential issue to raise approximately ₹173.5 crore.
- Combined capital infusion totals around ₹423.5 crore.
- Promoter Anupam Rasayan India Limited to invest ₹135 crore.
- Remaining investment to come from institutional investors.
- Preferential allotment remains subject to shareholder and regulatory approvals.
Utilisation of Funds:
The capital raised will support:
- Expansion into the R-32 refrigerant gas business.
- Growth of the company’s value-added fluorochemical portfolio.
- Strengthening of the balance sheet.
- Improvement in financial flexibility.
- Funding future strategic growth initiatives.
Strategic Importance:
- The capital raise significantly enhances TANFAC’s ability to execute long-term expansion plans while maintaining a prudent capital structure. Entry into the R-32 refrigerant gas segment broadens the company’s product portfolio and positions it to benefit from increasing demand for next-generation refrigerants and specialty fluorochemicals.
- The participation of both promoters and institutional investors also reflects confidence in the company’s long-term growth strategy.
Management Commentary:
- Managing Director Afzal Malkani stated that the successful completion of the QIP, followed by the proposed preferential issue, represents a significant milestone in TANFAC’s growth journey. He noted that the capital infusion would strengthen the company’s financial position, support planned investments, and enhance long-term value creation while maintaining a prudent capital structure.
Note:
- The company clarified that this filing replaces an incorrect press release that was inadvertently uploaded earlier on the BSE portal. The previous submission should be treated as withdrawn.
Risk Analysis
Summary:
- The fundraising is largely positive, although the preferential allotment remains subject to shareholder and regulatory approvals.
Key Risks:
- Preferential issue requires statutory and shareholder approvals.
- Equity issuance will result in some dilution for existing shareholders.
- Timely deployment of capital will determine the effectiveness of the expansion plans.
- Returns on investment depend on successful execution of the R-32 and fluorochemicals growth strategy.
Worst Case:
- Any delay in approvals or slower-than-expected execution of expansion projects could postpone the anticipated benefits from the capital raise and reduce the expected return on invested capital.
Risk Level: Low
Company Commentary
- TANFAC Industries stated that the combined capital raise of approximately ₹423.5 crore demonstrates continued confidence from both promoters and institutional investors in the company’s long-term strategy.
- The company intends to deploy the proceeds towards strategic expansion, strengthening its financial position, and building its presence in the R-32 refrigerant gas and value-added fluorochemical segments.
Official Exchange Filing: TANFAC Industries Limited
